VINORELBINE AFTER PACLITAXEL IN BREAST-CANCER - CROSS-RESISTANCE AND CUMULATIVE NEUROTOXICITY

被引：12

作者：

DITTRICH, C

ZIFKO, U

FAZENY, B

FIEGL, M

GRISOLD, W

HUBER, H

机构：

[1] LUDWIG BOLTZMANN INST APPL CANC RES,VIENNA,AUSTRIA

[2] FRANZ JOSEF HOSP,DEPT NEUROL,VIENNA,AUSTRIA

来源：

ANNALS OF ONCOLOGY | 1994年 / 5卷 / 05期

关键词：

D O I：

10.1093/oxfordjournals.annonc.a058886

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：473 / 474

页数：2

共 5 条

[1]

ARMAND JP, 1989, SEMIN ONCOL, V16, P41

[2]

BELPOMME D, 1991, 3RD P INT C NEOADJ C

[3]

FELLOUS A, 1989, SEMIN ONCOL, V16, P9

[4] PHASE-II TRIAL OF WEEKLY INTRAVENOUS VINORELBINE IN 1ST-LINE ADVANCED BREAST-CANCER CHEMOTHERAPY [J].

FUMOLEAU, P ;

DELGADO, FM ;

DELOZIER, T ;

MONNIER, A ;

DELGADO, MAG ;

KERBRAT, P ;

GARCIAGIRALT, E ;

KEILING, R ;

NAMER, M ;

CLOSON, MT ;

GOUDIER, MJ ;

CHOLLET, P ;

LECOURT, L ;

MONTCUQUET, P .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1245-1252

[5] TAXOL BINDS TO POLYMERIZED TUBULIN INVITRO [J].

PARNESS, J ;

HORWITZ, SB .

JOURNAL OF CELL BIOLOGY, 1981, 91 (02) :479-487

← 1 →